| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/18/2008 | US20080229447 Transformation of immature soybean seeds through organogenesis |
| 09/18/2008 | US20080229446 Expression vector comprising nucleotide sequences coding isomerase for use in generating plants with enhanced isoprenoid biosynthesis |
| 09/18/2008 | US20080229445 Plants Having Increased Yield and Method for Making the Same |
| 09/18/2008 | US20080229444 Transgenic plant expressing arsenate reductase; producing plants enhanced against metal accumulation |
| 09/18/2008 | US20080229441 Fungal endophytes of elymus canadensis |
| 09/18/2008 | US20080229439 Nucleic acid molecules and other molecules associated with transcription in plants and uses thereof for plant improvement |
| 09/18/2008 | US20080229438 Plasmid comprising nucleotide sequences coding human growth hormone for use in transformation and propagation in bovine embryos; bioreactors |
| 09/18/2008 | US20080228589 Methods For Placing, Accepting, And Filling Orders For Products and Services |
| 09/18/2008 | US20080227966 Expression vector comprising nucleotide sequences coding glyphosate resistant lyase for use in generation of herbicide resistant plants; controlling weed pest in transgenic crop field |
| 09/18/2008 | US20080227957 Reducing Immunogenicities of Immunoglobulins by Framework-Patching |
| 09/18/2008 | US20080227955 Nematode PAN and ZP Receptor-Like Sequences |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227741 Zap-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (cll/sll) |
| 09/18/2008 | US20080227740 Compositions and Methods for Elimination of Unwanted Cells |
| 09/18/2008 | US20080227739 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 09/18/2008 | US20080227737 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 09/18/2008 | US20080227736 Used to transduce heterologous genes into a cell and can be used for in vivo and ex vivo therapeutic applications, as well as for diagnostic and research tool applications |
| 09/18/2008 | US20080227734 Mutant Lrp5/6 Wnt-Signaling Receptors in Cancer Diagnosis, Prognosis, and Treatment |
| 09/18/2008 | US20080227733 Administering short interfering RNAs (siRNA) which modulates Fas-protein encoding gene expression for inhibiting Fas-protein regulated apoptosis in a cell |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227712 Polypeptide for use in treatment and prevention of leukemia, hemophilia and nervous system disorders |
| 09/18/2008 | US20080227711 Cxc-Chemokine Antagonists |
| 09/18/2008 | US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine |
| 09/18/2008 | US20080227704 CXCL13 binding proteins |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227699 Therapeutic Agent for Neurodegenerative Diseases |
| 09/18/2008 | US20080227698 oligopeptide antagonizes binding of DKK1 to LRP5 when in contact with LRP5; degenerative bone diseases |
| 09/18/2008 | US20080227697 Bacterial protein phosphoinositide probes and effectors |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227661 Mutant reverse transcriptase and methods of use |
| 09/18/2008 | US20080227659 Incrementally Truncated Nucleic Acids and Methods of Making Same |
| 09/18/2008 | US20080227654 Method for sequencing nucleic acid molecules |
| 09/18/2008 | US20080227652 Dna Array for Analyzing Dna Methylation, Method of Producing the Same and Method of Analyzing Dna Methylation |
| 09/18/2008 | US20080227650 Incrementally Truncated Nucleic Acids and Methods of Making Same |
| 09/18/2008 | US20080227639 non-coding regulatory element polynucleotide molecules isolated from the Metallothionein gene of Oryza sativa and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing Oryza |
| 09/18/2008 | US20080227205 Incorporation on Non-Naturally Encoded Amino Acids Into Proteins |
| 09/18/2008 | US20080227200 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 09/18/2008 | US20080227199 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227195 Expanding the eukaryotic genetic code |
| 09/18/2008 | US20080227193 Expression vector coding oxidoreductase for use in identifying modulators which prevent parasitic worm infection; nematocides; biological pest control |
| 09/18/2008 | US20080227192 Nematode ATP Synthase Subunit E-Like Sequences |
| 09/18/2008 | US20080227172 Sialyltransferase and dna encoding the same |
| 09/18/2008 | US20080227160 Using vector transformation to generate transgenic cells expressing interfering RNA sequences; treatment and prevention of metabolic disorders |
| 09/18/2008 | US20080227158 Novel polypeptide, novel dna and novel antibody |
| 09/18/2008 | US20080227157 Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album |
| 09/18/2008 | US20080227156 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/18/2008 | US20080227155 Pegylated soluble gp130-dimers useful as a medicament |
| 09/18/2008 | US20080227154 Protein Expression |
| 09/18/2008 | US20080227153 Site specific incorporation of keto amino acids into proteins |
| 09/18/2008 | US20080227152 In vivo incorporation of unnatural amino acids |
| 09/18/2008 | US20080227151 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227150 Transforming pichia with escherichia heat resistant acid phosphatase (APPA); monitor release of phosphorous from phytate |
| 09/18/2008 | US20080227149 Interferon-Alpha Polypeptides and Conjugates |
| 09/18/2008 | US20080227148 Aspergillus Promotors for Expressing a Gene in a Fungal Cell |
| 09/18/2008 | US20080227147 Lysosomal enzyme for use in destroying clostridial bacteria in chesse and milk products; improving food processing |
| 09/18/2008 | US20080227146 Immortalized Avian Cell Lines For Virus Production |
| 09/18/2008 | US20080227145 Filamentous Fungal Mutants With Improved Homologous Recombination Efficiency |
| 09/18/2008 | US20080227141 Transfection of vectors coding proteins into prokaryotic host cells, culturing, allowing to produce and accumulate isoprenoids consisting of ubiquinone, vitamin K2, and carotenoid |
| 09/18/2008 | US20080227138 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080227133 Recombinant klebsiella cleaving enzyme (Kpn1) for use as non-specialized gene cutting tool; gel electrophoresis; point mutations; site-directed mutagenesis |
| 09/18/2008 | US20080227132 Hydrolase Enzymes and Their Use in Kinetic Resolution |
| 09/18/2008 | US20080227131 P38 mitogen activated protein kinase fusion for use as reporter molecule in enzyme activation bioassays |
| 09/18/2008 | US20080227129 Using multimeric ubiquitin fusion protein as an enzyme activity indicator; destruction of reporter demonstrate enhanced enzyme activity |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227125 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 09/18/2008 | US20080227124 Multilayer support of polylactone or polyamide and cationic polymer; bioassay; kits |
| 09/18/2008 | US20080227122 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/18/2008 | US20080227110 Expression vector comprising nucleotide sequences coding human polypeptide for use in treatment of metabolic disorders; immunotherapy |
| 09/18/2008 | US20080227108 Using variation in internal transcribed spacers-1 as evaluative tool classifying fungal species |
| 09/18/2008 | US20080227107 Compositions and methods for labeling of nucleic acid molecules |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080227097 Fluorescent protein and chromoprotein |
| 09/18/2008 | US20080227093 Membrane protein; point mutations; antibodies; food processing and bitterness; phenotype analysis |
| 09/18/2008 | US20080227090 Methods, apparatus, and computer programs for verifying the integrity of a probe |
| 09/18/2008 | US20080227088 Using histone phosphorylation as evaluative tool in monitoring frequency of DNA breaks associated with smoking tobacco |
| 09/18/2008 | US20080227085 Methods and Systems for the Identification of Rna Regulatory Sequences and Compounds that Modulate their Function |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226768 Expression vector coding camel proteolytic enzyme for expression in milk products; food processing and cheese manufacturing |
| 09/18/2008 | US20080226753 Cry proteins; blending seed mixtures then planting; herbicide resistance |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226677 Recombinant virus vector for gene transfer into lymphoid cells |
| 09/18/2008 | US20080226675 Supplying genes to human cells; gene expression blocks; mutant lentivirus vectors; prevention, therapy aids |
| 09/18/2008 | US20080226673 Subunit vaccine against respiratory syncytial virus infection |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226661 Using immunoaffinity recognition to identify phage clones expressing mycoplasma peptides; developing vaccines for prevention and treatment of contagious bovine pleuropneumonia |
| 09/18/2008 | US20080226660 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 09/18/2008 | US20080226659 Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226649 Cytosine/guanine nucleotide sequences for use as therapeutic in treatment of allergy, asthma, cancer, infection, anemia, thrombocytopenia and neutropenia. |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |